Scinovex
reviewTop 1% cited

Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

Journal of Cerebral Blood Flow & Metabolism · 2016 · Vol. 36(9) · pp. 1481–1507
Ralf G. RempeAnika M. S. HartzBjörn Bauer

Abstract

Matrix metalloproteinases are versatile endopeptidases with many different functions in the body in health and disease. In the brain, matrix metalloproteinases are critical for tissue formation, neuronal network remodeling, and blood-brain barrier integrity. Many reviews have been published on matrix metalloproteinases before, most of which focus on the two best studied matrix metalloproteinases, the gelatinases MMP-2 and MMP-9, and their role in one or two diseases. In this review, we provide a broad overview of the role various matrix metalloproteinases play in brain disorders. We summarize and review current knowledge and understanding of matrix metalloproteinases in the brain and at the blood-brain barrier in neuroinflammation, multiple sclerosis, cerebral aneurysms, stroke, epilepsy, Alzheimer's disease, Parkinson's disease, and brain cancer. We discuss the detrimental effects matrix metalloproteinases can have in these conditions, contributing to blood-brain barrier leakage, neuroinflammation, neurotoxicity, demyelination, tumor angiogenesis, and cancer metastasis. We also discuss the beneficial role matrix metalloproteinases can play in neuroprotection and anti-inflammation. Finally, we address matrix metalloproteinases as potential therapeutic targets. Together, in this comprehensive review, we summarize current understanding and knowledge of matrix metalloproteinases in the brain and at the blood-brain barrier in brain disorders.

Protease and Inhibitor MechanismsPeptidase Inhibition and AnalysisBlood Coagulation and Thrombosis MechanismsMatrix metalloproteinaseBlood–brain barrierNeuroinflammationNeuroprotectionAngiogenesisMedicineNeuroscienceInflammationImmunologyCancer research

MeSH terms

Blood-Brain BarrierBrain DiseasesHumansMaleMatrix MetalloproteinasesMolecular Targeted Therapy

Funding

  • World Health Organization
  • National Institutes of Health
Citations
739
FWCI
12.31
field-weighted impact
References
315
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.